Cointime

Chinook Therapeutics

company

About

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

  • 11 - 50

Highlights

Total Funding Amount
$171M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$106M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. The company focuses on developing precision medicines for kidney diseases. Its services offers utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.

The company was founded in 2019 and headquartered in Alberta, Canada.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$171M
Chinook Therapeutics has raised a total of $171M in funding over 2 rounds. Their latest funding was raised on Aug 18, 2020 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 18, 2020 Post-IPO Equity $106M 2 — — Detail
Aug 22, 2019 Series A $65M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Chinook Therapeutics is funded by 2 investors. Northleaf Capital Partners and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Northleaf Capital Partners — Post-IPO Equity
Versant Ventures — Post-IPO Equity
Cointime
เนื้อหา
บริษัท